Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124536632 | 12453663 | 2 | F | 20160603 | 20160818 | 20160609 | 20160823 | PER | US-CELGENEUS-USA-2016061056 | CELGENE | 74.50 | YR | F | Y | 70.37000 | KG | 20160823 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124536632 | 12453663 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | B0027AF | 20785 | 200 | MG | CAPSULES | QD | |||||
| 124536632 | 12453663 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | B0027AF | 20785 | 200 | MG | CAPSULES | QD | |||||
| 124536632 | 12453663 | 3 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 200 MILLIGRAM | U | B0027AF | 20785 | 200 | MG | CAPSULES | QD | ||||
| 124536632 | 12453663 | 4 | C | TRADJENTA | LINAGLIPTIN | 1 | Oral | 0 | 5 | MG | UNKNOWN | QD | |||||||
| 124536632 | 12453663 | 5 | C | RENAGEL | SEVELAMER HYDROCHLORIDE | 1 | Oral | 0 | 800 | MG | UNKNOWN | BID | |||||||
| 124536632 | 12453663 | 6 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | 100 UN/ML | 0 | UNKNOWN | |||||||||
| 124536632 | 12453663 | 7 | C | Glyburide Micronized | 2 | Oral | 0 | 3 | MG | UNKNOWN | QD | ||||||||
| 124536632 | 12453663 | 8 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 0 | 12.5 | MG | UNKNOWN | QD | |||||||
| 124536632 | 12453663 | 9 | C | Fenofibrate Micronized | 2 | Oral | 0 | 200 | MG | UNKNOWN | QD | ||||||||
| 124536632 | 12453663 | 10 | C | Aspir-81 | ASPIRIN | 1 | Unknown | 5 MILLIGRAM | 0 | 81 | MG | UNKNOWN | |||||||
| 124536632 | 12453663 | 11 | C | APIDRA | INSULIN GLULISINE | 1 | Unknown | 100 UN/ML | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124536632 | 12453663 | 1 | Plasma cell myeloma |
| 124536632 | 12453663 | 4 | Diabetes mellitus |
| 124536632 | 12453663 | 5 | Chronic kidney disease |
| 124536632 | 12453663 | 6 | Diabetes mellitus |
| 124536632 | 12453663 | 7 | Diabetes mellitus |
| 124536632 | 12453663 | 8 | Hypertension |
| 124536632 | 12453663 | 9 | Lipids |
| 124536632 | 12453663 | 10 | Prophylaxis |
| 124536632 | 12453663 | 11 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124536632 | 12453663 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124536632 | 12453663 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124536632 | 12453663 | 1 | 200711 | 0 | ||
| 124536632 | 12453663 | 2 | 201001 | 0 | ||
| 124536632 | 12453663 | 3 | 20110426 | 0 | ||
| 124536632 | 12453663 | 4 | 20150408 | 0 | ||
| 124536632 | 12453663 | 5 | 20150408 | 0 | ||
| 124536632 | 12453663 | 6 | 20120131 | 0 | ||
| 124536632 | 12453663 | 7 | 20120131 | 0 | ||
| 124536632 | 12453663 | 8 | 20150408 | 0 | ||
| 124536632 | 12453663 | 9 | 20120131 | 0 | ||
| 124536632 | 12453663 | 10 | 20120131 | 0 | ||
| 124536632 | 12453663 | 11 | 20120131 | 0 |